> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Qvar Not Withdrawn Due to Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/qvar-not-withdrawn-due-to-safety-efficacy-fda/
- Published: 2019-04-05T12:00:00.000Z
- Updated: 2026-09-15T01:18:44.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5143801

*Federal Register* notice: FDA has determined that Teva’s Qvar 40 and Qvar 80 (beclomethasone dipropionate HFA) inhalation aerosol products were not withdrawn from sale for reasons of safety or effectiveness. The determination will allow the agency to approve ANDAs that reference the products if all other legal and regulatory requirements are met. Qvar is indicated for the maintenance treatment of asthma as a prophylactic therapy in patients five years of age and older. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-04-04/pdf/2019-06552.pdf?ref=fdaweb.com).